Delta 9 Cannabis Inc. Logo

Delta 9 Cannabis Inc.

DN.TO

(1.0)
Stock Price

0,01 CAD

-34.98% ROA

484.43% ROE

-0.06x PER

Market Cap.

1.510.885,00 CAD

-459.83% DER

0% Yield

-27.74% NPM

Delta 9 Cannabis Inc. Stock Analysis

Delta 9 Cannabis Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Delta 9 Cannabis Inc. Fundamental Stock Analysis
# Analysis Rating
1 Revenue Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

2 PBV

The stock's PBV ratio (1.98x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

3 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

4 ROE

The stock's ROE indicates a negative return (-375.67%) on shareholders' equity, suggesting poor financial performance.

5 ROA

The stock's ROA (-40.23%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 DER

The company has a high debt to equity ratio (2641%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

7 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Delta 9 Cannabis Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Delta 9 Cannabis Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Buy

Delta 9 Cannabis Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Delta 9 Cannabis Inc. Revenue
Year Revenue Growth
2003 0
2004 0 0%
2005 0 0%
2006 0 0%
2007 1.143.041 100%
2008 1.297.273 11.89%
2009 506.133 -156.31%
2010 514.632 1.65%
2011 545.803 5.71%
2012 369.189 -47.84%
2013 0 0%
2014 0 0%
2015 609.871 100%
2016 498.334 -22.38%
2017 944.114 47.22%
2018 7.569.283 87.53%
2019 31.765.960 76.17%
2020 52.047.053 38.97%
2021 62.291.436 16.45%
2022 63.228.271 1.48%
2023 73.745.116 14.26%
2023 71.065.337 -3.77%
2024 65.959.660 -7.74%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Delta 9 Cannabis Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2003 0
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Delta 9 Cannabis Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2003 0
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 1.988.755 100%
2009 841.516 -136.33%
2010 507.085 -65.95%
2011 262.090 -93.48%
2012 273.636 4.22%
2013 222.782 -22.83%
2014 192.215 -15.9%
2015 85.406 -125.06%
2016 1.447.712 94.1%
2017 7.137.571 79.72%
2018 9.603.215 25.68%
2019 9.765.166 1.66%
2020 9.346.941 -4.47%
2021 8.494.104 -10.04%
2022 19.206.535 55.77%
2023 16.517.376 -16.28%
2023 15.438.113 -6.99%
2024 17.909.320 13.8%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Delta 9 Cannabis Inc. EBITDA
Year EBITDA Growth
2003 -169.970
2004 -334.967 49.26%
2005 -2.130.704 84.28%
2006 -3.201.877 33.45%
2007 -3.040.587 -5.3%
2008 -672.134 -352.38%
2009 -960.397 30.01%
2010 -734.125 -30.82%
2011 -381.628 -92.37%
2012 -548.799 30.46%
2013 -200.455 -173.78%
2014 -236.448 15.22%
2015 -92.831 -154.71%
2016 -1.473.545 93.7%
2017 -7.647.884 80.73%
2018 -7.515.121 -1.77%
2019 1.472.337 610.42%
2020 3.235.852 54.5%
2021 -1.169.251 376.75%
2022 -12.451.609 90.61%
2023 -11.432.180 -8.92%
2023 -13.106.790 12.78%
2024 -11.355.040 -15.43%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Delta 9 Cannabis Inc. Gross Profit
Year Gross Profit Growth
2003 0
2004 0 0%
2005 0 0%
2006 0 0%
2007 691.157 100%
2008 -508.634 235.88%
2009 -338.703 -50.17%
2010 -433.230 21.82%
2011 -120.479 -259.59%
2012 -96.688 -24.61%
2013 0 0%
2014 -882 100%
2015 609.341 100.14%
2016 100.057 -508.99%
2017 442.681 77.4%
2018 5.738.812 92.29%
2019 16.401.459 65.01%
2020 17.998.266 8.87%
2021 17.319.276 -3.92%
2022 10.878.689 -59.2%
2023 10.894.628 0.15%
2023 -2.403.285 553.32%
2024 1.992.268 220.63%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Delta 9 Cannabis Inc. Net Profit
Year Net Profit Growth
2003 -170.353
2004 -335.405 49.21%
2005 -2.131.056 84.26%
2006 -2.983.362 28.57%
2007 -3.121.674 4.43%
2008 -3.346.698 6.72%
2009 368.131 1009.11%
2010 -1.194.935 130.81%
2011 -339.640 -251.82%
2012 -189.419 -79.31%
2013 632.014 129.97%
2014 -147.047 529.8%
2015 160.672 191.52%
2016 -1.352.668 111.88%
2017 -7.870.624 82.81%
2018 -8.485.573 7.25%
2019 13.744.589 161.74%
2020 -5.485.200 350.58%
2021 -11.142.227 50.77%
2022 -28.112.553 60.37%
2023 -21.901.072 -28.36%
2023 -17.515.339 -25.04%
2024 -20.279.940 13.63%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Delta 9 Cannabis Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2003 -1
2004 -1 0%
2005 -4 75%
2006 -3 -100%
2007 -3 0%
2008 -3 33.33%
2009 0 0%
2010 -1 100%
2011 -3 66.67%
2012 0 0%
2013 1 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Delta 9 Cannabis Inc. Free Cashflow
Year Free Cashflow Growth
2003 -138.520
2004 -598.860 76.87%
2005 -940.708 36.34%
2006 -3.603.022 73.89%
2007 -4.587.953 21.47%
2008 -433.105 -959.32%
2009 58.101 845.43%
2010 -417.752 113.91%
2011 -86.027 -385.61%
2012 -61.164 -40.65%
2013 -49.866 -22.66%
2014 -69.732 28.49%
2015 -89.451 22.04%
2016 -526.097 83%
2017 -4.877.737 89.21%
2018 -26.348.286 81.49%
2019 -26.164.028 -0.7%
2020 -4.330.902 -504.12%
2021 -3.354.982 -29.09%
2022 -6.020.802 44.28%
2023 2.569.877 334.28%
2023 623.961 -311.87%
2024 -346.474 280.09%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Delta 9 Cannabis Inc. Operating Cashflow
Year Operating Cashflow Growth
2003 -58.846
2004 -134.143 56.13%
2005 -287.926 53.41%
2006 -1.668.597 82.74%
2007 -1.651.542 -1.03%
2008 -219.924 -650.96%
2009 58.101 478.52%
2010 -411.870 114.11%
2011 -86.027 -378.77%
2012 -61.164 -40.65%
2013 -49.866 -22.66%
2014 -69.732 28.49%
2015 -11.209 -522.11%
2016 -519.495 97.84%
2017 -4.653.320 88.84%
2018 -8.827.465 47.29%
2019 -12.130.366 27.23%
2020 1.507.547 904.64%
2021 -775.478 294.4%
2022 -3.657.460 78.8%
2023 3.222.108 213.51%
2023 683.156 -371.65%
2024 -335.572 303.58%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Delta 9 Cannabis Inc. Capital Expenditure
Year Capital Expenditure Growth
2003 79.674
2004 464.717 82.86%
2005 652.782 28.81%
2006 1.934.425 66.25%
2007 2.936.411 34.12%
2008 213.181 -1277.43%
2009 0 0%
2010 5.882 100%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 78.242 100%
2016 6.602 -1085.13%
2017 224.417 97.06%
2018 17.520.821 98.72%
2019 14.033.662 -24.85%
2020 5.838.449 -140.37%
2021 2.579.504 -126.34%
2022 2.363.342 -9.15%
2023 652.231 -262.35%
2023 59.195 -1001.83%
2024 10.902 -442.97%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Delta 9 Cannabis Inc. Equity
Year Equity Growth
2003 771.185
2004 735.580 -4.84%
2005 853.097 13.78%
2006 6.636.335 87.15%
2007 3.514.661 -88.82%
2008 263.621 -1233.22%
2009 631.752 58.27%
2010 -27.768 2375.11%
2011 -591.901 95.31%
2012 -1.092.242 45.81%
2013 -460.228 -137.33%
2014 -607.275 24.21%
2015 300.429 302.14%
2016 468.507 35.88%
2017 24.556.398 98.09%
2018 35.305.169 30.45%
2019 34.429.620 -2.54%
2020 34.845.413 1.19%
2021 25.279.142 -37.84%
2022 6.538.571 -286.62%
2023 -6.426.447 201.74%
2023 -606.342 -959.87%
2024 -9.957.905 93.91%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Delta 9 Cannabis Inc. Assets
Year Assets Growth
2003 842.984
2004 759.187 -11.04%
2005 1.078.324 29.6%
2006 6.724.445 83.96%
2007 3.731.112 -80.23%
2008 717.138 -420.28%
2009 1.107.485 35.25%
2010 1.131.538 2.13%
2011 910.251 -24.31%
2012 134.325 -577.65%
2013 92.239 -45.63%
2014 15.255 -504.65%
2015 12.744 -19.7%
2016 16.517 22.84%
2017 25.035.802 99.93%
2018 45.975.616 45.55%
2019 66.156.981 30.51%
2020 76.401.444 13.41%
2021 74.781.304 -2.17%
2022 89.550.554 16.49%
2023 74.088.108 -20.87%
2023 80.450.792 7.91%
2024 70.229.985 -14.55%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Delta 9 Cannabis Inc. Liabilities
Year Liabilities Growth
2003 71.799
2004 23.607 -204.14%
2005 225.227 89.52%
2006 88.110 -155.62%
2007 216.451 59.29%
2008 453.517 52.27%
2009 475.733 4.67%
2010 1.159.306 58.96%
2011 1.502.152 22.82%
2012 1.226.567 -22.47%
2013 552.467 -122.02%
2014 622.530 11.25%
2015 462.604 -34.57%
2016 168.407 -174.69%
2017 479.404 64.87%
2018 10.670.447 95.51%
2019 31.727.361 66.37%
2020 41.556.031 23.65%
2021 49.502.162 16.05%
2022 83.011.983 40.37%
2023 80.514.555 -3.1%
2023 81.057.134 0.67%
2024 80.187.890 -1.08%

Delta 9 Cannabis Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.31
Net Income per Share
-0.09
Price to Earning Ratio
-0.06x
Price To Sales Ratio
0.02x
POCF Ratio
0.31
PFCF Ratio
0.42
Price to Book Ratio
-0.11
EV to Sales
0.92
EV Over EBITDA
-6.31
EV to Operating CashFlow
17.4
EV to FreeCashFlow
17.97
Earnings Yield
-17.1
FreeCashFlow Yield
2.39
Market Cap
0,00 Bil.
Enterprise Value
0,06 Bil.
Graham Number
0.29
Graham NetNet
-0.31

Income Statement Metrics

Net Income per Share
-0.09
Income Quality
-0.2
ROE
4.84
Return On Assets
-0.28
Return On Capital Employed
-1.19
Net Income per EBT
1.06
EBT Per Ebit
1.01
Ebit per Revenue
-0.26
Effective Tax Rate
-0.21

Margins

Sales, General, & Administrative to Revenue
0.22
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.02
Gross Profit Margin
0.08
Operating Profit Margin
-0.26
Pretax Profit Margin
-0.26
Net Profit Margin
-0.28

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.02
Free CashFlow per Share
0.02
Capex to Operating CashFlow
0.03
Capex to Revenue
0
Capex to Depreciation
0.01
Return on Invested Capital
-0.61
Return on Tangible Assets
-0.35
Days Sales Outstanding
11.67
Days Payables Outstanding
16.39
Days of Inventory on Hand
63.81
Receivables Turnover
31.28
Payables Turnover
22.26
Inventory Turnover
5.72
Capex per Share
0

Balance Sheet

Cash per Share
0,01
Book Value per Share
-0,04
Tangible Book Value per Share
-0.11
Shareholders Equity per Share
-0.04
Interest Debt per Share
0.23
Debt to Equity
-4.6
Debt to Assets
0.66
Net Debt to EBITDA
-6.17
Current Ratio
0.3
Tangible Asset Value
-0,02 Bil.
Net Current Asset Value
-0,06 Bil.
Invested Capital
14669025
Working Capital
-0,04 Bil.
Intangibles to Total Assets
0.2
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
11752818.5
Debt to Market Cap
30.75

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Delta 9 Cannabis Inc. Dividends
Year Dividends Growth

Delta 9 Cannabis Inc. Profile

About Delta 9 Cannabis Inc.

Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, decontamination pods, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. As of April 20, 2022, the company owned and operated 35 retail stores under the Delta 9 brand name across the Canadian Prairies. Delta 9 Cannabis Inc. was incorporated in 2001 and is headquartered in Winnipeg, Canada.

CEO
Mr. John William Arbuthnot IV
Employee
200
Address
P.O. Box 68096
Winnipeg, R3L 2V9

Delta 9 Cannabis Inc. Executives & BODs

Delta 9 Cannabis Inc. Executives & BODs
# Name Age
1 Mr. Marshall Posner
Chief Marketing Officer
70
2 Mr. James Lawson
Chief Financial Officer, Controller & Secretary
70
3 Mr. John William Arbuthnot IV
Co-Founder, Chief Executive Officer & Director
70
4 Mr. John William Arbuthnot III
Co-Founder & Director
70

Delta 9 Cannabis Inc. Competitors